logo
Sebi revised norms: Sebi updates audit committee norms for MIIs

Sebi revised norms: Sebi updates audit committee norms for MIIs

Time of India20-05-2025
Mumbai: The Securities and Exchange Board of India (Sebi) on Monday revised norms on the composition of audit committee and internal audit mechanism at market infrastructure institutions (MIIs).The regulator said the audit committee of the MII should not have any executive director including the managing director. The auditors of the MII and the key management personnel (KMP) would have a right to be heard in the meetings of the audit committee when it considers the auditors's report but would not have the right to vote, it said . Further, whenever required, the KMPs could be invited to attend the audit committee meetings with the permission of the chair but would not have the right to vote."The terms of reference of the audit committee amongst others involves approval of related-party transactions, scrutiny of financial statements, evaluation of internal financial controls and risk management systems, etc which requires objective evaluation of the functioning and decisions of the management," Sebi said.Sebi also said MIIs should conduct internal audit of functions and activities at least once in a financial year. Besides, internal auditor should be an independent audit firm and report only to the audit committee.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Case registered against Sahara Group chief Subrata Roy, family for embezzling Rs 72.82 crore from MP land sales
Case registered against Sahara Group chief Subrata Roy, family for embezzling Rs 72.82 crore from MP land sales

New Indian Express

time5 hours ago

  • New Indian Express

Case registered against Sahara Group chief Subrata Roy, family for embezzling Rs 72.82 crore from MP land sales

BHOPAL: Six months after launching an investigation into alleged irregularities in the sale of Sahara Group's land in multiple Madhya Pradesh cities, the state's Economic Offences Wing (EOW) registered a case on Friday against Sahara Group companies and top officials, accusing them of cheating and criminal conspiracy. Those named in the FIR registered under Sections 420 and 120B of the Indian Penal Code (IPC) include Sahara India, Sahara Prime City Limited, Seemanto Roy (Corporate Control Management), JB Roy (DGM-DMW), OP Srivastava (Deputy Managing Worker), and others. Two of the accused named in the FIR – Seemanto Roy and JB Roy – are the son and brother respectively of Sahara India Parivar's late chairman, Subrata Roy. Investigations by the state's economic offence watchdog have allegedly revealed that the Sahara Group embezzled Rs 72.82 crore from the sale of over 500 acres of land in five districts of Madhya Pradesh, including the state capital Bhopal, Jabalpur, Katni, Sagar, and Gwalior. The probe also allegedly found that the Sahara Group wilfully violated Supreme Court directives issued in 2012, 2014, and 2016. The company is accused of transferring Rs F72.82 crore from the sale of these assets to other accounts, instead of depositing the proceeds in the SEBI-Sahara Refund Account, which was established for refunding lakhs of small investors across India.

Sebi, exchanges revise ESM applicability for firms below ₹1,000 cr mcap
Sebi, exchanges revise ESM applicability for firms below ₹1,000 cr mcap

Business Standard

time8 hours ago

  • Business Standard

Sebi, exchanges revise ESM applicability for firms below ₹1,000 cr mcap

The Securities and Exchange Board of India (Sebi) and exchanges have revised the enhanced surveillance mechanism (ESM) framework for companies with market capitalisation lower than ₹1,000 crore. The new framework will be applicable from July 28. The decision to revise shortlisting criteria and norms for stage-wise movement under the framework was taken in a joint meeting on July 25. The changes are expected to benefit 28 companies. Along with the existing shortlisting criteria based on high-low price variations, positive close-to-close price variation over the last three months have also been added as a requirement for moving a scrip to ESM stage 1. This refe₹to a consistent increase in the prices of the shares of a company over the past three months, indicating increased interest from the investors. Further, price to earnings ratio (PE) has also been added as one of the conditions for shifting a scrip from stage 1 to stage 2 of the ESM framework. A PE of up to 2-times the PE of the benchmark index Nifty 500 has been set as one of the requirements. Last year in August, the market regulator had expanded the ESM framework to mainboard companies under ₹1,000 crore mcap. The ESM framework is for monitoring and surveillance of listed companies based on price variation, standard deviation, etc. The framework is also applicable on small and micro companies. If the company is in stage 1 of the framework, 100 per cent margin is applicable from T+2 day and the trade for trade settlement will be with the price band of 5 per cent. If the scrip already has a price band of 2 per cent, then that will continue. The stage-wise review of stocks — for lower stage revision and exit — is done on a weekly basis.

Samara Capital-backed Sahajanand Medical Tech files IPO papers with Sebi
Samara Capital-backed Sahajanand Medical Tech files IPO papers with Sebi

News18

time9 hours ago

  • News18

Samara Capital-backed Sahajanand Medical Tech files IPO papers with Sebi

New Delhi, Jul 26 (PTI) Cardiac stent maker Sahajanand Medical Technologies (SMT) Ltd has filed preliminary papers with the capital markets regulator Sebi to raise funds through an initial public offering (IPO). The IPO is entirely an offer-for-sale (OFS) of 2.76 crore equity shares by promoters and investors, according to the draft red herring prospectus (DRHP) filed on Friday. Those selling shares in the public issue are Shree Hari Trust, Samara Capital Markets Holding, Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding BV. Samara Capital Markets Holding, Kotak Pre-IPO Opportunities Fund, Plutus Wealth Management LLP, and Ashish Kacholia are major shareholders in the company. Founded in 2001, Sahajanand Medical Technologies is engaged in the development of medical devices, with an emphasis on Vascular Intervention and Structural Heart. It has two R&D centres, one in India and another in Thailand. Additionally, it has built an intellectual property portfolio, with 102 patents granted globally, 71 more patent applications in the pipeline, and five design registrations in India. The company's revenue from operations increased by 13.67 per cent to Rs 1,025 crore in fiscal 2025 from Rs 902 crore in the preceding fiscal. Its profit stood at Rs 25 crore compared to a loss of Rs 7.35 crore. Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management are the book-running lead managers. Earlier, the company had filed draft papers with Sebi in September 2021 for raising Rs 1,500 crore through its IPO. This comprised fresh issuance as well as OFS. However, Sahajanand Medical Technologies didn't go ahead with the public issue. PTI SP BAL BAL view comments First Published: July 26, 2025, 16:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store